The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Interleukin 8 and cardiovascular disease
Abstract
Since the establishment of the inflammatory basis of atherosclerosis, several pro- or anti-inflammatory agents have been examined as potential mediators of the biochemical pathways of lesion formation. Interleukin (IL)-8 was first characterized in 1987. Since then, knowledge regarding its role in leucocyte trafficking and activation has advanced rapidly, especially in the field of cardiovascular disease. In the scientific literature, there is sufficient evidence to support beyond any doubt the involvement of IL-8 in the establishment and preservation of the inflammatory micro-environment of the insulted vascular wall. However, how the information derived from in vitro studies and animal models can be applied in clinical practice has yet to be determined. In the present review, the available evidence regarding the role of IL-8 in cardiovascular disease is presented, and future perspectives are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013 · cited 1×
“GRO-a immobilized on the surface of ECs via heparin proteoglycans induce the firm adhesion of rolling monocytes expressing CXCR2(17), whereas FKN as a structurally unique chemokine fused to a transmembrane mucin stalk acts as an efficient adhesion molecule through an integrin-independent mechanism.(20) MCP-1 takes the…”
BackgroundRoss, R., & Glomset, J. A. (1973) · Science · doi:10.1126/science.180.4093.1332 · Cited by 1,501
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,244
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Quinn, M. T., Parthasarathy, S., Fong, L. G., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2995 · Cited by 1,137
Structure and Functional Expression of a Human Interleukin-8 Receptor
Holmes, W. E., Lee, J., Kuang, W.-J., Rice, G. C., & Wood, W. I. (1991) · Science · doi:10.1126/science.1840701 · Cited by 1,090
Cloning of Complementary DNA Encoding a Functional Human Interleukin-8 Receptor
Murphy, P. M., & Tiffany, H. L. (1991) · Science · doi:10.1126/science.1891716 · Cited by 871
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 776
The chemokine system: redundancy for robust outputs
Mantovani, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01469-3 · Cited by 704
Standiford, T. J., Kunkel, S. L., Basha, M. A., Chensue, S. W., Lynch, J. P., Toews, G. B., Westwick, J., & Strieter, R. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114928 · Cited by 687
Structure, Function, and Inhibition of Chemokines
Fernandez, E. J., & Lolis, E. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091901.115838 · Cited by 609
Boisvert, W. A., Santiago, R., Curtiss, L. K., & Terkeltaub, R. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1195 · Cited by 518
Kim, C.-S., Park, H.-S., Kawada, T., Kim, J.-H., Lim, D., Hubbard, N. E., Kwon, B.-S., Erickson, K. L., & Yu, R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803259 · Cited by 511 · cited 1×
“These findings suggest that circulating MCP-1 and/or IL-8 may be a potential marker, linking obesity with obesity-related metabolic complications such as atherosclerosis and diabetes.(76) Similarly, in primary prevention, Trøseid et al.”
BackgroundEndothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions
Gimbrone, M. A., Obin, M. S., Brock, A. F., Luis, E. A., Hass, P. E., Hébert, C. A., Yip, Y. K., Leung, D. W., Lowe, D. G., Kohr, W. J., et al. (1989) · Science · doi:10.1126/science.2688092 · Cited by 452
Regulation of interleukin 8 gene expression by oxidant stress.
DeForge, L. E., Preston, A. M., Takeuchi, E., Kenney, J., Boxer, L. A., & Remick, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74429-9 · Cited by 392
Henrichot, E., Juge-Aubry, C. E., Pernin, A., Pache, J.-C., Velebit, V., Dayer, J.-M., Meda, P., Chizzolini, C., & Meier, C. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000188508.40052.35 · Cited by 382
Rezaie-Majd, A., Maca, T., Bucek, R. A., Valent, P., Müller, M. R., Husslein, P., Kashanipour, A., Minar, E., & Baghestanian, M. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022694.16328.cc · Cited by 379
Chemokines in Atherosclerosis: An Update
Zernecke, A., Shagdarsuren, E., & Weber, C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161174 · Cited by 376
Chemokines in acute respiratory distress syndrome
Puneet, P., Moochhala, S., & Bhatia, M. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00405.2003 · Cited by 313
IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways
Schraufstatter, I. U., Chung, J., & Burger, M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1094 · Cited by 278
Weber, C., Weber, K. S. C., Klier, C., Gu, S., Wank, R., Horuk, R., & Nelson, P. J. (2001) · Blood · doi:10.1182/blood.v97.4.1144 · Cited by 262
Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.
Yue, T. L., Wang, X., Sung, C. P., Olson, B., McKenna, P. J., Gu, J. L., & Feuerstein, G. Z. (1994) · Circulation Research · doi:10.1161/01.res.75.1.1 · Cited by 260
Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.
McMurray, H. F., Parthasarathy, S., & Steinberg, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116605 · Cited by 252
Kawamura, T., Wakusawa, R., Okada, K., & Inadat, S. (1993) · Canadian Journal of Anaesthesia · doi:10.1007/bf03009470 · Cited by 252
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Weber, C., Schober, A., & Zernecke, A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142812.03840.6f · Cited by 244
Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood.
DeForge, L. E., Fantone, J. C., Kenney, J. S., & Remick, D. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116097 · Cited by 233
IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue
Simonini, A., Moscucci, M., Muller, D. W. M., Bates, E. R., Pagani, F. D., Burdick, M. D., & Strieter, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1519 · Cited by 225
Weber, K. S. C., von Hundelshausen, P., Clark-Lewis, I., Weber, P. C., & Weber, C. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<700::aid-immu700>3.0.co;2-1 · Cited by 209
Chemokine/chemokine receptor nomenclature
(2003) · Cytokine · doi:10.1016/s1043-4666(02)00493-3 · Cited by 198
Hashmi, S., & Zeng, Q. T. (2006) · Coronary Artery Disease · doi:10.1097/01.mca.0000236288.94553.b4 · Cited by 191
Liu, Y., Hultén, L. M., & Wiklund, O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.317 · Cited by 187
Trøseid, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.006 · Cited by 187
Moreau, M., Brocheriou, I., Petit, L., Ninio, E., Chapman, M. J., & Rouis, M. (1999) · Circulation · doi:10.1161/01.cir.99.3.420 · Cited by 180
Chemokine signalling: pivoting around multiple phosphoinositide 3‐kinases
Curnock, A. P., Logan, M. K., & Ward, S. G. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01345.x · Cited by 176
Weber, C., Kraemer, S., Drechsler, M., Lue, H., Koenen, R. R., Kapurniotu, A., Zernecke, A., & Bernhagen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804017105 · Cited by 175
Cytokines and cardiovascular disease
Mehra, V. C., Ramgolam, V. S., & Bender, J. R. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405182 · Cited by 174
Interleukin-8 Production by Macrophages From Atheromatous Plaques
Apostolopoulos, J., Davenport, P., & Tipping, P. G. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1007 · Cited by 165
Herder, C., Baumert, J. J., Thorand, B., Martin, S., Löwel, H., Kolb, H., & Köenig, W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000235691.84430.86 · Cited by 141
Inoue, T., Komoda, H., Nonaka, M., Kameda, M., Uchida, T., & Node, K. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.012 · Cited by 135
N’Guessan, P. D., Riediger, F., Vardarova, K., Scharf, S., Eitel, J., Opitz, B., Slevogt, H., Weichert, W., Hocke, A. C., Schmeck, B., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178319 · Cited by 125
Inhibition Of Interleukin-8 Blocks Myocardial Ischemia-Reperfusion Injury
Boyle, E. M., Kovacich, J. C., Hébert, C. A., Canty, T. G., Chi, E. Y., Morgan, E. N., Pohlman, T. H., & Verrier, E. D. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70249-1 · Cited by 110
Ischemia-Induced Interleukin-8 Release After Human Heart Transplantation
Öz, M. C., Liao, H., Naka, Y., Seldomridge, A., Becker, D. N., Michler, R. E., Smith, C. R., Rose, E. A., Stern, D. M., & Pinsky, D. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.428 · Cited by 91
Selectin‐P and interleukin‐8 plasma levels in coronary heart disease patients
Romuk, E. B., Skrzep-Poloczek, B., Wojciechowska, C., Tomasik, A. R., Birkner, E., Wodniecki, J., Gabrylewicz, B., Ochala, A. J., & Tendera, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01053.x · Cited by 84
Chemokine regulation of atherosclerosis
Barlic, J., & Murphy, P. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206761 · Cited by 81
Zhou, R., Shi, Q., Gao, H., & Shen, B.-J. (2001) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.8.30 · Cited by 63
Transient rise in serum interleukin-8 concentration during acute myocardial infarction.
Abe, Y., Kawakami, M., Kuroki, M., Yamamoto, T., FUJII, M., Kobayashi, H., Yaginuma, T., Kashii, A., Saito, M., & Matsushima, K. (1993) · Heart · doi:10.1136/hrt.70.2.132 · Cited by 47
Wu, Z., Laurikka, J. O., Vikman, S., Nieminen, R. M., Moilanen, E., & Tarkka, M. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9758-7 · Cited by 47
Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes
de Winter, R. J., Manten, A., de Jong, Y. P., Adams, R., van Deventer, S. J. H., & Lie, K. I. (1997) · Heart · doi:10.1136/hrt.78.6.598 · Cited by 45
Ryoo, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.002 · Cited by 41
Tziakas, D. N., Chalikias, G. K., Tentes, I. K., Stakos, D., Chatzikyriakou, S. V., Mitrousi, K., Kortsaris, A. X., Kaski, J. C., & Boudoulas, H. K. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn382 · Cited by 40
Riesenberg, K., Levy, R., Katz, A., et al. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1270667.x · Cited by 36
Nandate, K., Vuylsteke, A., Crosbie, A. E., Messahel, S., Oduro, A., & Menon, D. K. (1999) · Anesthesia & Analgesia · doi:10.1213/00000539-199910000-00003 · Cited by 31
Mussack, T., Briegel, J., Schelling, G., Biberthaler, P., & Jochum, M. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.044 · Cited by 27
Ganaha, F., Kao, E. Y., Wong, H., Elkins, C. J., Lee, J., Modanlou, S., Rhee, C., Kuo, M., Yüksel, E., Cifra, P. N., et al. (2004) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000127888.70058.93 · Cited by 25
Interleukin 8 and Susceptibility to Coronary Artery Disease: a Population Genetics Perspective.
Vogiatzi, K., Apostolakis, S. Z., Voudris, V. V., et al. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9194-3 · Cited by 22
Self-citation
Cited by
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Quagliariello, V., De Laurentiis, M., Rea, D., Barbieri, A., Monti, M. G., Carbone, A., Paccone, A., Altucci, L., Conte, M., Canale, M. L., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01346-y · Cited by 367
Randomized controlled trial for time-restricted eating in healthy volunteers without obesity
Xie, Z., Sun, Y., Ye, Y., Hu, D., Zhang, H., He, Z., Zhao, H., Yang, H., & Mao, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-28662-5 · Cited by 276
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
Aho, V., Ollila, H. M., Rantanen, V., Kronholm, E., Surakka, I., van Leeuwen, W. M. A., Lehto, M., Matikainen, S., Ripatti, S., Härmä, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077184 · Cited by 93
Metadata
- Authors
- Apostolakis, S., Vogiatzi, K., Amanatidou, V., & Spandidos, D. A.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-18
- Volume
- 84
- Issue
- 3
- Pages
- 353-360
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2131918803
- Cited by
- 285
- References
- 58
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.